OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript

Page 4 of 4

Phillip Frost: Yeah, I was going to say, it was effectively the total patient volume year-over-year was consistent there. It was plus or minus about 0.5%. Sequentially, it continues to be a stable — a stable business as well. We’re seeing good growth in the specialty lines of testing that the team has been focused on.

Dipesh Patel: Great. Thank you very much.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Dr. Frost for any closing remarks.

Phillip Frost: I like to thank everybody for attending our conference call and if you have any further questions feel free to call anyone of us, will try to respond, and then we’ll look forward to meeting together again at the end of next quarter. Thank you.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Opko Health Inc. (NYSE:OPK)

Page 4 of 4